Low prevalence of vancomycin-resistant enterococci in clinical samples from hospitalized patients of the Canary Islands, Spain

International Microbiology

Volumn 5, Issue 3, 2002, Pages 117-120

  Pérez Hernández, Xiomara ^a,d   Méndez Álvarez, Sebastián ^a,b   Delgado, Teresa ^c   Moreno, Antonio ^a   Reyes Darias, Jose Antonio ^a   Sierra López, Antonio ^c   Villar, Jesús ^a   González, Agustín ^d   Sánchez, Antonio Manuel Martín ^e   Macía, Manuel ^a   Claverie Martín, Félix ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Antibiotic resistance; Enterococcus; Glycopeptide; Prevalence

Indexed keywords

ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS GALLINARUM;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; ENTEROCOCCUS; GENE FREQUENCY; GENETICS; HOSPITALIZATION; HUMAN; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; SPAIN; STAPHYLOCOCCUS AUREUS;

ENTEROCOCCUS; GENE FREQUENCY; HOSPITALIZATION; HUMANS; METHICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; SPAIN; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 0036729640     PISSN: 11396709     EISSN: 16181905     Source Type: Journal    
DOI: 10.1007/s10123-002-0075-y     Document Type: Article

References (23)

1. Arthur M, Reynolds P, Courvalin P (1996) Glycopeptide resistance in enterococci. Trends Microbiol 4:401-407
2. Cetinkaya Y, Falk P, Mayhall CG (2000) Vancomycin-resistant enterococci. Clin Microbiol Rev 13:686-707
3. Cisterna R, Ibarra K, Morla A, Basaras M, Cisterna C, Herreras A, Borja J, Grupo Español de Estudio y Vigilancia de Resistencias (1999) Estudio multicéntrico de resistencias en enterococos. Papel de la teicoplanina. Rev Esp Quimioter 12:237-243
4. Dutka-Malen S, Evers S, Courvalin P (1995) Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33:24-27
5. Endtz HP, van den Braak N, Verbrugh HA, van Belkum A (1999) Vancomycin resistance: status quo and quo vadis. Eur J Clin Microbiol Infect Dis 18:683-690
6. B two-component regulatory system in Enterococcus faecalis V583. J Bacteriol 178:1302-1309
7. Fackland RR, Sham DF, Teixeira LM (1999) Enterococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology, 7th edn. American Society for Microbiology, Washington, D.C., pp 297-305
8. Fines M, Perichon B, Reynolds P, Sahm DF, Courvalin P (1999) VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 43:2161-2164
9. Gold HS (2001) Vancomycin-resistant enterococci: mechanism and clinical observations. Clin Infect Dis 33:210-219
10. Ke D, Picard FJ, Martineau F, Menard C, Roy PH, Ouellette M, Bergeron MG (1999) Development of a PCR assay for rapid detection of enterococci. J Clin Microbiol 37:3497-3503
11. Low DE, Keller N, Barth A, Jones RN (2001) Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY antimicrobial surveillance program, 1977-1999. Clin Infect Dis 15 [Suppl 2]: S133-145
12. McKessar SJ, Berry AM, Bell JM, Turnidge JD, Paton JC (2000) Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother 44:3224-3228
13. Méndez-Alvarez S, Pérez-Hernández X, Claverie-Martín F (2000) Glycopeptide resistance in enterococci. Int Microbiol 3:71-80
14. Murray BE (2000) Vancomycin-resistant enterococcal infections. N Engl J Med 342:710-721
15. National Committee for Clinical Microbiology Standards (1997) Performance standards for antimicrobial susceptibility tests. Approved standard M2-A6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Ostrowsky BE, Clark NC, Thauvin-Eliopoulus C, Venkataraman L, Samore MH, Tenover FC, Eliopoulus GM, Moellering RC Jr, Gold HS (1999) A cluster of VanD.vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology. J Infect Dis 180:1177-1185
17. Pérez-Hernández X, Méndez-Álvarez S, Claverie-Martín F (2002) A rapid PCR assay for rapid detection of vancomycin-resistant enterococci. Diagn Microbiol Infect Dis 42:273-277
18. Pérez-Roth E, Claverie-Martín F, Batista N, Moreno A, Méndez-Alvarez S (2002) Mupirocin resistance in methicillin resistant Staphylococcus aureus clinical isolates in a Spanish hospital. Co-application of multiplex PCR assay and conventional microbiology methods. Diagn Microbiol Infect Dis 43 (in press)
19. Périchon B, Reynolds P, Courvalin P (1997) VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 41:2016-2018
20. Peset V, Tallon P, Sola C, Sanchez E, Sarrion A, Perez-Belles C, Vindel A, Canton E, Gobernado M (2000) Epidemiological, microbiological, clinical and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. Eur J Clin Microbiol Infect Dis 19:742-749
21. Rice LB (2001) Emergence of vancomycin-resistant enterococci. Emerg Infect Dis 7:183-187
22. Schouten MA, Hoogkamp-Korstanje JAA, Meis JFG, Voss A, The European VRE Study Group (2000) Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 19:816-822
23. Woodford N (1998) Glycopeptide-resistant enterococci: a decade of experience. J Med Microbiol 47:849-862